Evidence map›Paper›PMID 38318814›Full record

ArticleCancer biology & medicine2024

Road of no return - loss of TP53 paves a defined evolution path from gastric preneoplasia-to-cancer.

Liwei An, Yi Han, Shi Jiao, Zhaocai Zhou

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biology & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Liwei AnState Key Laboratory of Genetic Engineering, Zhongshan Hospital, School of Life Sciences, Fudan University, Shanghai 200438, China.
Yi HanDepartment of Stomatology, Shanghai Tenth People's Hospital, Department of Biochemistry and Molecular Biology, Tongji University School of Medicine, Shanghai 200072, China.
Shi JiaoState Key Laboratory of Genetic Engineering, Zhongshan Hospital, School of Life Sciences, Fudan University, Shanghai 200438, China.
Zhaocai ZhouState Key Laboratory of Genetic Engineering, Zhongshan Hospital, School of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0000-0002-5441-3922

Funding

National Key R&D Program of China 2017YFA0504504National Key R&D Program of China 2020YFA0803200National Natural Science Foundation of China 32070710National Natural Science Foundation of China 82222052Science and Technology Commission of Shanghai Municipality 22QA1407300Science and Technology Commission of Shanghai Municipality 23YF1432900Science and Technology Commission of Shanghai Municipality 23ZR1480400Talent Climbing Project from Shanghai Tenth People's Hospital 2021SYPDRC003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Stomach NeoplasmsCarcinogenesisHumansTumor Suppressor Protein p53TP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID38318814
PMCPMC10845934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.